What is the typical treatment for a yeast infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Yeast Infections

For typical vaginal yeast infections (vulvovaginal candidiasis), treatment with topical azole antifungals or oral fluconazole is highly effective, with cure rates of 80-90% for uncomplicated cases. 1

First-Line Treatment Options

Topical Treatments

  • Butoconazole 2% cream: Apply 5g intravaginally for 3 days 1
  • Clotrimazole 1% cream: Apply 5g intravaginally for 7-14 days 1
  • Clotrimazole 100mg vaginal tablet: Insert one tablet daily for 7 days 1
  • Clotrimazole 100mg vaginal tablet: Insert two tablets daily for 3 days 1
  • Clotrimazole 500mg vaginal tablet: Insert as a single application 1, 2
  • Miconazole 2% cream: Apply 5g intravaginally for 7 days 1
  • Miconazole 200mg vaginal suppository: Insert one suppository daily for 3 days 1
  • Miconazole 100mg vaginal suppository: Insert one suppository daily for 7 days 1
  • Terconazole 0.4% cream: Apply 5g intravaginally for 7 days 1
  • Terconazole 0.8% cream: Apply 5g intravaginally for 3 days 1
  • Terconazole 80mg vaginal suppository: Insert one suppository daily for 3 days 1
  • Tioconazole 6.5% ointment: Apply 5g intravaginally as a single application 1

Oral Treatment

  • Fluconazole 150mg: Take as a single oral dose 1, 3

Treatment Selection Guidelines

For Uncomplicated Vulvovaginal Candidiasis

  • Single-dose treatments are appropriate for mild-to-moderate cases 1
  • Multi-day regimens (3-7 days) are preferred for severe or complicated infections 1
  • Many topical preparations (butoconazole, clotrimazole, miconazole, tioconazole) are available over-the-counter 1, 2

For Complicated Cases

  • Recurrent vulvovaginal candidiasis (RVVC) may require longer treatment courses 4
  • Non-albicans Candida species may be less susceptible to fluconazole and require alternative treatments 4, 5

Important Considerations

Diagnosis

  • Diagnosis should be confirmed by symptoms (pruritus, vaginal discharge, soreness) plus either:
    • Wet preparation/Gram stain showing yeasts/pseudohyphae, or
    • Positive culture for yeast species 1
  • Normal vaginal pH (≤4.5) is typical with Candida infections 1
  • 10-20% of women normally harbor Candida without symptoms, so identification of Candida without symptoms does not require treatment 1

Self-Treatment

  • Self-medication with OTC preparations is appropriate only for women with previously diagnosed VVC experiencing recurrence of the same symptoms 1
  • Women whose symptoms persist after using OTC preparations or who experience recurrence within 2 months should seek medical care 1

Special Populations

  • Pregnant women can be treated with topical azoles 1
  • HIV-positive patients should receive the same treatment as HIV-negative patients 1

Efficacy Comparison

  • Topically applied azole drugs are more effective than nystatin 1
  • Treatment with azoles results in relief of symptoms and negative cultures in 80-90% of patients who complete therapy 1
  • While terbinafine has been studied for vulvovaginal candidiasis, it showed lower mycologic cure rates (33.3%) compared to fluconazole (66.6%) and is not recommended as first-line treatment 6

Common Pitfalls to Avoid

  • Treating without confirming diagnosis can lead to inappropriate therapy 1
  • Failing to complete the full course of treatment may result in recurrence 1
  • Ignoring persistent symptoms after treatment may allow progression of infection 1
  • Not considering non-albicans Candida species in treatment failures 4, 5
  • Concurrent bacterial vaginosis may be present and should be considered in cases that don't respond to antifungal therapy alone 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Antifungal agents.

The Medical journal of Australia, 2007

Research

The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis.

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.